|
Volumn 48, Issue 4, 2000, Pages 923-931
|
Intraarterial 192Ir high-dose-rate brachytherapy for prophylaxis of restenosis after femoropopliteal percutaneous transluminal angioplasty: The prospective randomized Vienna-2-trial radiotherapy parameters and risk factors analysis
|
Author keywords
192Ir endovascular brachytherapy; Femoropopliteal arteries; Percutaneous transluminal angioplasty; Risk factors for restenosis
|
Indexed keywords
IRIDIUM 192;
IRIDIUM;
ADULT;
AGED;
ANGIOGRAPHY;
ARTICLE;
BRACHYTHERAPY;
CLAUDICATION;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIABETES MELLITUS;
DOPPLER ECHOGRAPHY;
FEMALE;
FEMOROPOPLITEAL BYPASS;
GRAFT PATENCY;
HUMAN;
LIMB ISCHEMIA;
MAJOR CLINICAL STUDY;
MALE;
PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY;
PRIORITY JOURNAL;
RADIATION DOSE;
RANDOMIZED CONTROLLED TRIAL;
RECURRENCE RISK;
RESTENOSIS;
RISK FACTOR;
STENOSIS;
TREATMENT OUTCOME;
FEMORAL ARTERY;
INTERMITTENT CLAUDICATION;
METHODOLOGY;
MIDDLE AGED;
PERIPHERAL OCCLUSIVE ARTERY DISEASE;
POPLITEAL ARTERY;
PROSPECTIVE STUDY;
RECURRENT DISEASE;
RISK ASSESSMENT;
STENOSIS, OCCLUSION AND OBSTRUCTION;
ADULT;
AGED;
AGED, 80 AND OVER;
ANGIOPLASTY, BALLOON;
ARTERIAL OCCLUSIVE DISEASES;
BRACHYTHERAPY;
CONSTRICTION, PATHOLOGIC;
FEMALE;
FEMORAL ARTERY;
HUMANS;
INTERMITTENT CLAUDICATION;
IRIDIUM RADIOISOTOPES;
MALE;
MIDDLE AGED;
POPLITEAL ARTERY;
PROSPECTIVE STUDIES;
RECURRENCE;
RISK ASSESSMENT;
RISK FACTORS;
|
EID: 0034310724
PISSN: 03603016
EISSN: None
Source Type: Journal
DOI: 10.1016/S0360-3016(00)00716-1 Document Type: Article |
Times cited : (56)
|
References (42)
|